Mild COVID linked to widespread sleep disturbances

Doctors already knew that a Covid-19 infection bad enough to hospitalize someone is often followed by insomnia, but a new study of patients with recent mild Covid-19 has shown that these patients are very vulnerable to sleep disturbances, too.

COTA & Sanofi Partner to Leverage Real-World Data and AI to Accelerate Cancer Trials

What You Should Know: – COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi. – The

April 17, 2024

Cellusion shares pipeline update for eye disease stem cell therapy – Pharmaceutical Technology

Keratoconus of eye, 4th degree. Credit: Garna Zarina via Shutterstock Cellusion plans to begin a Phase I/II trial for its bullous keratopathy candidate CSL-001 in

June 28, 2023

Nanoparticle vaccine may offer safe and effective protection against Dabie Bandavirus

Cleveland Clinic researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV),

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.